Management Team

Aino Kalervo

MSc, MS, Chief Operating Officer

Chief Operating Officer, Aino Kalervo, is trained in both molecular biology and business and has over a decade’s experience in the business development of early stage biologics and therapeutic vaccines. Prior to joining TILT, Aino worked at Sanofi’s Paris office and Theravectys, a French therapeutic vaccine company. Aino is responsible for all aspects of business, including fund raising, business development, and bridging the gap from breakthrough science to product success.

Akseli Hemminki

MD, PhD, eMBA, Founder & CEO and Member of the Board of Directors

Kari Varkila

MD, PhD, MBA, Chief Medical Officer

Tuija Keinonen

PhD, Prof, Chief Regulatory Officer, Chair of the Board of Directors

Juha Pihlman

BSc, CFO consultant

Suvi Sorsa

PhD, VP of Clinical Affairs

Víctor Cervera-Carrascón

PhD, VP of Business Development

Hanna Kirk

MSc, VP of Product Development

Riikka Havunen

PhD, VP of Operations

John Goldfinch

MBA, CRM, US Clinical Lead

Elina Haavisto

MSc, Head of CMC Regulatory Affairs

Claudia Kistler

PhD, Head of Clinical Operations

João Manuel Santos

PhD, Head of Translational Medicine

Henrik Roosvall

BSc, Head of Business Operations

James Clubb

MSc, Head of Biomarker Research

Dafne Quixabeira

PhD, Project Manager

Katja Saarikko

Operations Coordinator

Sini Raatikainen

MSc, Lab Manager

Sanae Zahraoui

Supply Chain Manager

Lyna Haybout

MD, Medical Monitor

Minna Oksanen

MSc, Office Manager

Remi Gloeckler

PhD, CMC Advisor